6 studies were found.

1.		Recruiting	Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma or High-Risk Stage I Non-Hodgkin's Lymphoma Conditions: AIDS-related diffuse large cell lymphoma; AIDS-related immunoblastic large cell lymphoma; AIDS-related peripheral/systemic lymphoma; ...
2.		Recruiting	Combination Chemotherapy Followed By Antiviral Therapy and Interferon alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma Conditions: stage I adult T-cell leukemia/lymphoma; stage II adult T-cell leukemia/lymphoma; stage III adult T-cell leukemia/lymphoma; ...
3.		Not yet recruiting	Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma Conditions: epidemic Kaposi's sarcoma; recurrent Kaposi's sarcoma
4.		Recruiting	Topical Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma Conditions: epidemic Kaposi's sarcoma; recurrent Kaposi's sarcoma
5.		Not yet recruiting	Valproic Acid in Treating Patients With Kaposi’s Sarcoma Conditions: recurrent Kaposi's sarcoma; epidemic Kaposi's sarcoma
6.		Not yet recruiting	Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder Conditions: adult Burkitt's lymphoma; adult diffuse large cell lymphoma; indolent, adult non-Hodgkin's lymphoma; post-transplant lymphoproliferative disorder